Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency

Conway, GS; Szarras-Czapnik, M; Racz, K; Keller, Anita; Chanson, P; Tauber, M; Zacharin, M; 1369, GHD to GHDA Transition Study Group (2009). Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency. European journal of endocrinology, 160(6), pp. 899-907. Bristol: BioScientifica Ltd. 10.1530/EJE-08-0436

Full text not available from this repository. (Request a copy)

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine

UniBE Contributor:

Vuissoz, Jean-Marc

ISSN:

0804-4643

Publisher:

BioScientifica Ltd.

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:13

Last Modified:

08 Jun 2016 10:54

Publisher DOI:

10.1530/EJE-08-0436

Web of Science ID:

000272934600003

URI:

https://boris.unibe.ch/id/eprint/32402 (FactScience: 197559)

Actions (login required)

Edit item Edit item
Provide Feedback